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INTRODUCTION
The genus Phlomis belonging to family Labiatea consists of about 100 species in
the world. [1, 2] Some Phlomis species are used as tonics and stimulants in Anatolian
folk medicine. [3]  Different Phlomis species are used in folk medicine as stimu-
lant, tonic, analgesic, anti-diarrheal and considered useful for the treatment of
ulcers, hemorrhoids and airways disorders. There are a few reports on the phar-
macological activities, such as anti-inflammatory, immunosuppressive, anti mu-
tagenic, anti-nociceptive, antifibrile, anti-oxidant, anti-malarial and anti-mi-
crobial effects. [4] The present work has led to the isolation of a known labdane
type diterpene for the first time from Phlomis bracteosa, identified as marrubiin,
which in pharmacological investigation revealed spasmolytic and Ca++ antago-
nistic effects.
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ABSTRACT
Extraction, Isolation and structure elucidation
The whole plant of Phlomis bracteosa was dried in shade, chopped and ground to
coarse powder. The powdered plant (3 Kg) was initially extracted with methanol
for 25 days at room temp. The combined methanolic extract was evaporated
under reduced pressure giving residue (165 g). Using separating funnel, the metha-
nol extract was partitioned applying different solvents i.e., hexane, chloroform,
ethyl acetate, butanol and water (in order of increasing polarity) successively. [5]
A portion of the ethyl acetate extract (70 g) was chromatographed over a silica
gel column. The elution was carried out with a gradient of increasing polarity of
hexane, ethyl acetate, and methanol. Fraction B was obtained through elution
with n-hexane-ethyl acetate (1:1) and was subjected to column chromatography
with the solvent system (n-hexane-ethyl acetate).Compound (1) was ob-
tained from this fraction after eluting with n-hexane-ethyl acetate (3:7). Com-
pound (1) was further purified by recrystallization from methanol. Column
Chromatography (CC) was performed using silica gel, 70–230 mesh. Flash chro-
matography was carried out using silica gel 230–400 mesh. Thin layer chroma-
tography (TLC) was performed with precoated silica gel G-25-UV254 plates and
visualization was achieved using (UV, 254 nm) and by ceric sulphate in 10 %
H2SO4 solution Silica gel (E. Merck, 230–400 mesh) was used for column chro-
matography. The IR and UV Spectra were recorded on a Jasco-320-A and Hitachi-
UV-240 spectrophotometers, respectively. Optical rotations were measured on
a Jasco-DIP-360-digital polarimeter using a 10-cm cell-tube. Mass spectra (EI-
and HR-EI-MS) were measured in an electron impact mode on Finnigan MAT 12
or MAT 312 spectrophotometers; ions are presented in m/z (%). The 1H-and
13C-NMR spectra were recorded on a Bruker AMX-400 spectrometer in CDCl3.
The 2D-NMR spectra were recorded on Bruker AMX-400 spectrometer. Chemi-
cal shifts in parts per million (ä), relative to tetra methyl silane as an internal
standard, and scalar coupling were reported in Hertz. The pulse conditions were
as follows: for 1H-NMR spectra, spectrometer frequency (SF) 400.032 MHz,
acquisition time (AQ) 2.281 s, number of transients (NS) 128, receiver gain
(RG) 812.7, temperature (TE) 300K, dwell time (DW) 69.6ms, per scan delay
(DE)10ms, dummy scans (DS) 0, F1 2431.15 Hz, F2–1.77 Hz; for the 
13C-NMR
spectra SF100.613 MHz, AQ 0.6 + 26 s, NS 25000, RG 16384, TE 300 K, DW
19.1ms, DE 20ms, DS2, F1 23157.50 Hz; for the COSY 45
o spectra SF 400.03
MHz, NS32, DS4, pulse (P1) 5.70 ms, P22.70 µs, TE 300 K, RG 267.4, DW
145.6ms, DE 10ms; for the NOESY experiments SF 300.133 MHz, NS 64, DE
305ms, pulse width (PW) 0.0, F1 2903.69 Hz, F2 2903.69 Hz; for the HMQC
spectra, SF 400.032 MHz, AQ 0.1491s, NS 32, DS 16, DE 10 ms, DW 145.6ms,
RG 6502, TE 300 K, F1 1688.52 Hz, F2 3071.71 Hz; for the HMBC spectra SF
400.032 MHz, AQ 0.1491 s, RG 7296.2, NS 128, DW 145.6ms, DS 16, DE 10
ms, TE 300 K, F1 3212.30  Hz, F2 23236.21 Hz.
MATERIALS AND METHODS
Plant material
Whole parts of Phlomis bracteosa were collected from Swat, NWFP, Pakistan
in July 2005 and identified by Muhammad Naveed, Assistant Professor Botany
Department University of Peshawar NWFP Pakistan. A Voucher Specimen was
deposited in the Herbarium of the college.
A tricyclic labdane type diterpene was isolated for the first time from ethyl acetate soluble part of Phlomis bracteosa. Its structure was confirmed by  x-ray which
was found to be  marrubiin.When studied in isolated rabbit jejunum, marrubiin caused concentration-dependent relaxation of spontaneous and high K+ (80 mM)-
induced contractions, like that caused by verapamil, indicating that marrubiin exhibits spasmolytic activity, possibly mediated through Ca++ channel blocking
action.
Key words: Phlomis bracteosa, labiatae, marrubiin, antispasmodic,  Ca++ antagonist.
Figure 1. Structure of compound 1, marrubiin, a labdane type diterpene
isolated from Phlomis bracteosa
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Figure 3. Concentration-dependent inhibitory effect of (A) marrubiin,
X-rays analysis
The conditions for recording the spectra and the instruments have been de-
scribed in (Sigitdinova et al., 1996).[6]
Chemicals and animals
Acetylcholine (ACh) and verapamil were obtained from Sigma Chemicals Co.
Statistical analysis
The data expressed are mean ± standard error of mean (SEM) and analyzed by
using GraphPad program (GraphPAD, San Diego, CA, USA).
When tested in isolated rabbit jejunum, marrubiin inhibited the spontaneous
contractions with EC50 value of 1.3 mM (n=3), thus showing an antispasmodic
effect (Figure 2A). Similarly verapamil, used as a positive control drug, relaxed
the spontaneous contractions with EC50 values of 0.31 mM (n=3) as shown in
Figure 2B. The contraction of smooth muscle preparations, including rabbit
jejunum is dependent upon an increase in the cytoplasmic free [Ca++], which
activates the contractile elements. [10] The increase in intracellular Ca++ is due to
either influx via voltage dependant L-type Ca++ channels (VDCs) or to release
from intracellular stores in the sarcoplasmic reticulum. Periodic depolarization
regulates the spontaneous movements of intestine and at the height of depolar-
ization the action potential appears as a rapid influx of Ca++ via VDCs.[11] The
inhibitory effect of the plant compound on spontaneous movements of je-
junum.
RESULTS AND DISCUSSION
The ethyl acetate fraction obtained from methanolic extract of Phlomis
bracteosa was subjected to silica gel column chromatography eluted with ethyl
acetate hexane (8:2), afforded labdane type diterpene, compound 1 (Figure 1).
It was isolated in white powder form and its molecular formula established as
C20H28O4 by x-rays and spectral techniques. By comparison its data with litera-
ture showed, that it is marrubiin.
Determination of calcium antagonist activity
To assess whether the antispasmodic effect of the test compound is mediated
through calcium channel blockade, high K+ (80 mM) was used to depolarize the
preparations as described by Farre et al.[9] . Addition of high K+ to the tissue bath
produced a sustained contraction. Relaxation of intestinal preparations by the
compound, precontracted with K+, was expressed as percent of the control
response mediated by K+.
Antispasmodic effect
The spasmolytic activity of the test compound was studied by using isolated
rabbit jejunum as described previously. [8]  Respective segments of 2-cm length
were suspended in a 10 ml of Tyrode’s solution and bubbled with carbogen gas at
37°C.  The composition of the Tyrode’s solution in mM was KCl 2.68, NaCl
136.9, MgCl2 1.05, NaHCO3 11.90, NaH2PO4 0.42, CaCl2 1.8, and glucose 5.55.
A resting tension of 1 g was applied to each of the tissues and was kept constant
throughout the experiment. Intestinal responses were recorded isotonically
using a Bioscience transducer and Oscillograph. Each tissue was allowed to
equilibrate for at least 30 min before the addition of any drug and then stabilized
with a sub-maximal concentration of acetylcholine (0.3 µM) and the bath fluid
was subsequently replaced with normal Tyrode solution before starting the ex-
periment. Under these experimental conditions, rabbit jejunum exhibits sponta-
neous rhythmic contractions, allowing testing of the relaxant (spasmolytic)
activity directly without the use of any agonist.
form and methanol were from Merck (Darmstadt, Germany). Chemicals used
for making physiological salt solutions were potassium chloride (Sigma Chemi-
cals Co, St. Louis, MO, USA), calcium chloride, glucose, magnesium chloride,
sodium bicarbonate, sodium dihydorgen phosphate (Merck, Darmstadt, Ger-
many) and sodium chloride (BDH Laboratory supplies, Poole, England). All
chemicals used were of the analytical grade. Rabbits (1.2-1.5 kg) of either sex or
local breed were used in this study, housed at the Animal House of the Aga Khan
University, maintained at 23-25°C and given a standard diet and tap water.
Rabbits had free access to water, but food was withdrawn 24 hrs prior to experi-
ment and killed by a blow on the back of the head. Experiments performed
complied with the rulings of the Institute of Laboratory Animal Resources,
Commission on Life Sciences, National Research Council  [7] and were approved
by the Ethical Committee of the Aga Khan University
(St. Louis, MO, USA). The solvents, n-butanol, ethyl acetate, n-hexane, chloro
isolated from Phlomis bracteosa and (B) verapamil on K+-induced con-
tractions of isolated rabbit jejunum preparations. Values shown are
mean ± SEM, n=3.
Figure 2. Concentration-dependent inhibitory effect of (A) marrubiin,
isolated from Phlomis bracteosa and (B) verapamil on spontaneous con-
tractions of isolated rabbit jejunum preparations. Values shown are
mean ± SEM, n=3.
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may be due to interference either with the Ca++ release or with the Ca++ influx
through VDCs. In our earlier studies, we have observed that the spasmolytic
effect of the natural compounds is usually mediated through Ca++ channel block-
ade.[12-15] To see whether the spasmolytic effect of marrubiin is also mediated via
the same mechanism, it was tested against high K+ (80 mM)-induced contrac-
tions, which was relaxed by marrubiin with EC50 value of 1.4 µM (n=3) as shown
in Figure 3A. At high concentration (> 30 mM), K+ is known to cause smooth
muscle contractions through opening of VDCs, thus allowing influx of extracel-
lular Ca++ causing a contractile effect [16] and a substance causing inhibition of the
high K+-induced contraction is considered an inhibitor of the Ca++ influx.[17]
Verapamil, a standard Ca++ antagonist[18]  inhibited the high K+ (80 mM)-induced
contractions with EC50 values of 0.13 µM (n=3) as shown in Figure 3B. Thus the
spasmolytic effect of the marrubiin may be visualized as the Ca++ channel block-
ade mechanism.
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